Medicinal Mushroom Market Analysis 2026

Global Medicinal Mushroom Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Medicinal Mushroom Market Report Description

We have various report editions of Medicinal Mushroom Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Medicinal Mushroom Market Insights Video

Competitive Landscape of the Medicinal Mushroom Market

The market for medicinal mushrooms is extremely competitive, and major players include Hokkaido Reishi, Banken Champignons B.V., Far West Fungi, Swadeshi Mushroom, and Gourmet Mushrooms Ltd. These businesses provide a variety of mushroom supplements in the form of capsules, powders, and extracts and concentrate on product creation driven by research. The potency of bioactive substances, organic certifications, sourcing methods, and quality all influence competition. In order to attract health-conscious customers, market leaders place a strong emphasis on openness, sustainable sourcing, and stringent testing. In order to gain market share, new competitors also take advantage of e-commerce sites and increased consumer interest in functional foods, which makes rivalry in this quickly developing sector more fierce.

In September 2024, Applied Food Sciences, Inc. (AFS) announced the establishment of a new, cutting-edge cultivation facility in Finland as part of the extension of its strategic cooperation with KÄÄPÄ Biotech. This development reflects the companies' shared commitment to creating the best Nordic-origin mushrooms and responds to the growing demand for premium medicinal mushrooms globally. (Source: https://appliedfoods.com/afs-and-kaapa-biotech-build-new-cultivation-facility/ ) In December 2021, Psyence Group Inc. stated that it has teamed with "vida e caffè," one of Africa's biggest coffee retail chains, to launch its GOODMINDTM functional mushroom brand in a few of its coffee shops in South Africa. (Source: https://psyence.com/2021/12/02/psyence-group-functional-mushroom-brand-goodmind-commences-national-roll-out-in-south-africas-largest-coffee-retail-chain/) In August 2021, Leading international psychedelics firm Silo Wellness Inc. signed a statewide distribution arrangement with Essex-based LocoSoco Group Plc, a U.K. brand distributor, in accordance with a distribution agreement dated August 4, 2021. LocoSoco is designated as the sole distributor of Silo Wellness' whole line of Marley One-branded mushroom products in the United Kingdom by the Distribution Agreement. (Source: https://silowellness.com/press-release/silo-wellness-brings-marley-one-mushrooms-to-the-u-k-market-through-distribution-agreement-with-locosoco-limited/)

Top Companies Market Share in Medicinal Mushroom Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Medicinal Mushroom Market

Which Region Dominates the Medicinal Mushroom Market in 2024?

According to Cognitive Market Research, North America currently dominates the Medicinal Mushrooms market, and the region is expected to have significant growth during the projected period. The market for medicinal mushrooms is expanding in North America due to increasing consumer enthusiasm for therapeutic foods and herbal supplements. Due to consumer desire for products that improve immunity and cognitive function, the US leads the market. Turkey Tail, Lion's Mane, and Reishi mushrooms are well-liked because of their alleged health advantages. Additionally, Canada exhibits consistent growth, with a robust organic and wellness industry that complements medicinal mushrooms. Growing retail and e-commerce channels are facilitating accessibility in both nations and product innovation is sparked by studies on the health advantages of mushrooms. Possibilities exist in producing premium, organic-certified goods that satisfy consumer demands for potency and purity.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). Traditional customs and contemporary health trends are driving the thriving Asia-Pacific medicinal mushroom industry. The market is dominated by China and Japan, whose traditional medicine has traditionally used mushrooms like shiitake, cordyceps, and reishi. Due to its wealth of cultivation resources and knowledge, China is a significant producer and exporter. Research and innovation are prioritized in Japan, particularly in the fields of functional foods and supplements. With growing customer interest in natural health goods, South Korea and India also contribute to growth. While e-commerce and wellness trends generate additional growth potential, growing markets throughout the area are supported by growing knowledge of the immunological and cognitive benefits of mushrooms.

The current report Scope analyzes Medicinal Mushroom Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Medicinal Mushroom Market Analysis

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 14085.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Medicinal Mushroom market with a market size of USD 11113.70 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. Demand is being increased by consumers' increased attention to immunity and health, particularly in the wake of COVID-19. The US industry is still expanding due to the popularity of wellness products and natural supplements.
• The Canada Medicinal Mushroom market had a market share of USD 1690.30 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Demand is being driven by the wellness industry's growing preference for organic, plant-based supplements as well as consumers' growing interest in functional foods as they relate to their health.
• The Mexico Medicinal Mushroom market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 1281.81 million in 2024.

Europe Medicinal Mushroom Market Analysis

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 10564.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• The United Kingdom Medicinal Mushroom market had a market share of USD 1774.81 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. The demand is supported by a robust market for natural, nutritional foods and supplements, particularly in UK cities where consumers place a high value on mental and immunological health.
• The France Medicinal Mushroom market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 971.92 million in 2024.
• According to Cognitive Market Research, the German Medicinal Mushroom market size was valued at USD 2091.74 million in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period. The need for medicinal mushrooms, particularly for goods related to immunological and cognitive health, is supported by Germany's robust nutraceutical and functional food markets as well as its high level of knowledge of preventative healthcare.
• The Italy Medicinal Mushroom market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 908.53 million in 2024.
• The Russian Medicinal Mushroom market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 1637.47 million in 2024.
• The Spain Medicinal Mushroom market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 866.28 million in 2024
• The Luxembourg Medicinal Mushroom market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 327.49 million in 2024.
• The Portugal Medicinal Mushroom market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 221.85 million in 2024.
• The Greece Medicinal Mushroom market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 126.77 million in 2024.
• The Rest of Europe's Medicinal Mushroom market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 1637.47 million in 2024.

Asia Pacific Medicinal Mushroom Market Analysis

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 8099.34 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Medicinal Mushroom market size was valued at USD 3644.70 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period. Traditional Chinese medicine relies heavily on medicinal mushrooms, and the demand for goods like Reishi and Cordyceps in the food, pharmaceutical, and supplement industries is driven by growing health consciousness.
• The Japan Medicinal Mushroom market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 1117.71 million in 2024.
• The India Medicinal Mushroom market had a market share of USD 971.92 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. Demand is influenced by rising middle-class demand for natural supplements and growing awareness of wellness and preventive health. The advantages of medicinal mushrooms in India are in line with the market for herbal remedies and Ayurveda.
• The South Korean Medicinal Mushroom market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 809.93 million in 2024.
• The Australian Medicinal Mushroom market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 421.17 million in 2024.
• The South East Asia Medicinal Mushroom market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 558.85 million in 2024.
• The Rest of Asia Pacific Medicinal Mushroom market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 575.05 million in 2024.

South America Medicinal Mushroom Market Analysis

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 1760.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Medicinal Mushroom market size was valued at USD 753.59 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. One important factor is the growing acceptance of natural health products and alternative treatment among urban dwellers. In Brazil, interest in organic products and immune-boosting vitamins is rising.
• Argentina's Medicinal Mushroom market had a market share of USD 295.80 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Interest in natural supplements is growing due to rising health consciousness and the need for immunological support, especially in Argentina's urban areas where wellness trends are common.
• Colombia Medicinal Mushroom market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 156.70 million in 2024.
• Peru Medicinal Mushroom market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 144.38 million in 2024.
• Chile's Medicinal Mushroom market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 126.77 million in 2024.
• The Rest of Latin America's Medicinal Mushroom market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 283.48 million in 2024.

Middle East Medicinal Mushroom Market Analysis

According to Cognitive Market Research, the global Medicinal Mushroom market size was estimated at USD 35214.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 704.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031..

• The GCC Countries Medicinal Mushroom market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 301.44 million in 2024. In GCC countries, demand is driven by an increasing emphasis on health and well-being as well as an increased knowledge of alternative medicines, particularly in high-income markets like the UAE and Saudi Arabia.
• The Egypt Medicinal Mushroom market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 73.95 million in 2024.
• The South Africa Medicinal Mushroom market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 111.28 million in 2024. A growing interest in herbal medicine and health consciousness supports the demand for medicinal mushrooms. In South African cities that prioritize wellness, mushrooms are being utilized more and more as natural health supplements and to boost the immune system.
• The Turkey Medicinal Mushroom market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 60.57 million in 2024.
• The Nigeria Medicinal Mushroom market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 73.95 million in 2024.
• The Rest of the MEA Medicinal Mushroom market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 83.11 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.